Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ejps.2008.06.001
DC FieldValue
dc.titleModulation of breast cancer resistance protein (BCRP/ABCG2) by non-basic chalcone analogues
dc.contributor.authorHan, Y.
dc.contributor.authorRiwanto, M.
dc.contributor.authorGo, M.-L.
dc.contributor.authorRachel Ee, P.L.
dc.date.accessioned2014-10-29T01:55:58Z
dc.date.available2014-10-29T01:55:58Z
dc.date.issued2008-09-02
dc.identifier.citationHan, Y., Riwanto, M., Go, M.-L., Rachel Ee, P.L. (2008-09-02). Modulation of breast cancer resistance protein (BCRP/ABCG2) by non-basic chalcone analogues. European Journal of Pharmaceutical Sciences 35 (1-2) : 30-41. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ejps.2008.06.001
dc.identifier.issn09280987
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/106158
dc.description.abstractChalcones are biosynthetic precursors of flavonoids found to possess cytotoxic and chemopreventive activities. In this study, 17 non-basic chalcone analogues were synthesized and evaluated for their ability to modulate the function of either the human wild-type (482R) or mutant (482T) breast cancer resistance protein (BCRP/ABCG2) stably expressed in breast cancer MDA-MB-231 cells. At 5 μM, chalcones with 2,4-dimethoxy groups or 2,4-dihydroxyl groups on ring A were found to increase mitoxantrone accumulation to a greater extent than an established BCRP inhibitor, fumitremorgin C. At the same time, these chalcones had negligible effect on calcein accumulation in P-glycoprotein overexpressing MDCKII cells, indicating their potential as selective BCRP inhibitors. Functionally, these compounds were able to increase the sensitivity of BCRP-overexpressing cancer cells to mitoxantrone by 2-5-fold. The effect of chalcone compounds on both wild-type and mutant BCRP ATPase activity was also examined and variable effects were observed. A stimulatory effect was mostly observed with chalcones with 2,4-dimethoxy substitution on ring A which were earmarked as good BCRP inhibitors in the MX accumulation and cytotoxicity assays. These findings underscore the potential of methoxylated and hydroxylated chalcones as selective and potent inhibitors of BCRP whose mode of action may not involve the inhibition of ATPase activity. © 2008 Elsevier B.V. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ejps.2008.06.001
dc.sourceScopus
dc.subjectBreast cancer resistance protein
dc.subjectChalcones
dc.subjectDrug accumulation
dc.subjectInhibitors
dc.subjectMultidrug resistance
dc.typeArticle
dc.contributor.departmentPHARMACY
dc.description.doi10.1016/j.ejps.2008.06.001
dc.description.sourcetitleEuropean Journal of Pharmaceutical Sciences
dc.description.volume35
dc.description.issue1-2
dc.description.page30-41
dc.description.codenEPSCE
dc.identifier.isiut000259311000005
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

38
checked on Aug 5, 2020

WEB OF SCIENCETM
Citations

36
checked on Jul 28, 2020

Page view(s)

74
checked on Aug 1, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.